• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向抑制 MCT4 会破坏细胞内 pH 稳态,并赋予肝癌自我调控的细胞凋亡能力。

Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma.

机构信息

School of Life Science, Chongqing University, Chongqing, 400044, PR China.

Breast Cancer Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400044, PR China.

出版信息

Exp Cell Res. 2019 Nov 1;384(1):111591. doi: 10.1016/j.yexcr.2019.111591. Epub 2019 Aug 31.

DOI:10.1016/j.yexcr.2019.111591
PMID:31479685
Abstract

The high lactate production rate in hepatocellular carcinoma cells (HCC) have a profound impact on their malignant properties. In adaptation to the enhanced lactate stress, lactate-effusing monocarboxylate transporter 4(MCT4) is usually overexpressed in a broad range of HCC subtypes. In this study, the MCT4-mediated lactate efflux in HCC was blocked using microRNA-145(miR-145), which would force the endogenously generated lactate to accumulate within tumor cells in a self-regulated manner, resulting in the acidification of the cytoplasmic compartment as well as partial neutralization for pH in the tumor extracellular environment. Evaluations on multiple representative HCC subtypes (HepG2, Hep3B and HuH7) suggested that the disrupted pH homeostasis would amplify the lactate stress to initiate HCC apoptosis, while at the same time also suppressing their migration and invasion abilities. Moreover, safety tests on 7702 cells and living animals revealed that MCT4-blockade treatment has no cytotoxicity against healthy cells/tissues. The results indicate the MCT4-inhibition-induced disruption of tumor intracellular pH holds promise as a therapy against not only HCC, but a broader spectrum of MCT4-overexpressing hyperglycolytic tumors.

摘要

肝癌细胞(HCC)中高乳酸的产生速率对其恶性特性有深远的影响。在适应增强的乳酸应激中,乳酸外排单羧酸转运蛋白 4(MCT4)通常在广泛的 HCC 亚型中过表达。在这项研究中,使用 microRNA-145(miR-145)阻断 HCC 中的 MCT4 介导的乳酸外排,这将迫使内源性产生的乳酸以自我调节的方式在肿瘤细胞内积累,导致细胞质区室酸化以及肿瘤细胞外环境中 pH 的部分中和。对多种代表性 HCC 亚型(HepG2、Hep3B 和 HuH7)的评估表明,破坏的 pH 平衡会放大乳酸应激,引发 HCC 细胞凋亡,同时抑制其迁移和侵袭能力。此外,对 7702 细胞和活体动物的安全性测试表明,MCT4 阻断治疗对健康细胞/组织没有细胞毒性。这些结果表明,MCT4 抑制诱导的肿瘤细胞内 pH 破坏有望成为不仅针对 HCC 而且针对更广泛的 MCT4 过表达高糖酵解肿瘤的治疗方法。

相似文献

1
Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma.靶向抑制 MCT4 会破坏细胞内 pH 稳态,并赋予肝癌自我调控的细胞凋亡能力。
Exp Cell Res. 2019 Nov 1;384(1):111591. doi: 10.1016/j.yexcr.2019.111591. Epub 2019 Aug 31.
2
Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas.肝细胞癌中一元羧酸转运体4和磷脂酰肌醇蛋白聚糖-3的肿瘤内相互表达
BMC Res Notes. 2019 Nov 9;12(1):741. doi: 10.1186/s13104-019-4778-y.
3
Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.单羧酸转运蛋白4预示肝细胞癌预后不良,并与细胞增殖和迁移相关。
J Cancer Res Clin Oncol. 2015 Jul;141(7):1151-62. doi: 10.1007/s00432-014-1888-8. Epub 2014 Dec 2.
4
Involvement of SLC16A1/MCT1 and SLC16A3/MCT4 in l-lactate transport in the hepatocellular carcinoma cell line.SLC16A1/MCT1 和 SLC16A3/MCT4 参与肝癌细胞系中 l-乳酸的转运。
Biopharm Drug Dispos. 2022 Oct;43(5):183-191. doi: 10.1002/bdd.2329. Epub 2022 Sep 22.
5
Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.异常的 MCT4 和 GLUT1 表达与肝癌切除术后早期复发和预后不良相关。
Cancer Med. 2018 Nov;7(11):5339-5350. doi: 10.1002/cam4.1521. Epub 2018 Oct 10.
6
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.单羧酸转运蛋白4抑制通过增强T细胞浸润和免疫攻击来增强肝细胞癌免疫治疗效果。
Hepatology. 2023 Jan 1;77(1):109-123. doi: 10.1002/hep.32348. Epub 2022 Feb 7.
7
Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.单羧酸转运蛋白 4 与滑液酸化有关,是炎症性关节炎的一个新的治疗靶点。
Arthritis Rheumatol. 2015 Nov;67(11):2888-96. doi: 10.1002/art.39270.
8
Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis.敲低 SLC16A3 可降低肝癌细胞外的乳酸浓度,减轻缺氧并诱导铁死亡。
Biochem Biophys Res Commun. 2024 Nov 12;733:150709. doi: 10.1016/j.bbrc.2024.150709. Epub 2024 Sep 18.
9
Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.单羧酸转运蛋白 4(MCT4)是一种高亲和力转运蛋白,能够在高乳酸微环境中输出乳酸。
J Biol Chem. 2019 Dec 27;294(52):20135-20147. doi: 10.1074/jbc.RA119.009093. Epub 2019 Nov 12.
10
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.选择性抑制乳酸转运蛋白 MCT4 可减少浸润性膀胱癌的生长。
Mol Cancer Ther. 2018 Dec;17(12):2746-2755. doi: 10.1158/1535-7163.MCT-18-0107. Epub 2018 Sep 27.

引用本文的文献

1
Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation.癌症耐药中的免疫细胞代谢:靶点发现与临床转化进展
Chin J Cancer Res. 2025 Jun 30;37(3):432-445. doi: 10.21147/j.issn.1000-9604.2025.03.11.
2
MCT4: a key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment.单羧酸转运蛋白4:影响胃癌转移并参与调节转移性免疫微环境的关键因子。
J Transl Med. 2025 Mar 5;23(1):276. doi: 10.1186/s12967-025-06279-8.
3
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma.
葡萄糖的代谢重编程:肝细胞癌发生发展的代谢基础。
Front Oncol. 2025 Feb 6;15:1545086. doi: 10.3389/fonc.2025.1545086. eCollection 2025.
4
Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets.心血管疾病中的乳酸代谢与乳酸化:新机制与治疗靶点
Front Cardiovasc Med. 2024 Nov 27;11:1489438. doi: 10.3389/fcvm.2024.1489438. eCollection 2024.
5
Role of lactate and lactate metabolism in liver diseases (Review).乳酸及乳酸代谢在肝脏疾病中的作用(综述)。
Int J Mol Med. 2024 Jul;54(1). doi: 10.3892/ijmm.2024.5383. Epub 2024 May 24.
6
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.糖酵解途径中的转录调控和翻译后修饰在靶向癌症治疗中的作用。
Acta Pharmacol Sin. 2024 Aug;45(8):1533-1555. doi: 10.1038/s41401-024-01264-1. Epub 2024 Apr 15.
7
A precise prognostic signature in CTNNB1-mutant hepatocellular carcinoma: Prognosis prediction and precision treatment exploration.CTNNB1 突变型肝细胞癌的精准预后特征:预后预测与精准治疗探索
Heliyon. 2023 Nov 14;9(12):e22382. doi: 10.1016/j.heliyon.2023.e22382. eCollection 2023 Dec.
8
Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure.乳酸与免疫调节之间的相互作用及其在肝衰竭诊治中的价值。
Open Life Sci. 2023 Sep 11;18(1):20220636. doi: 10.1515/biol-2022-0636. eCollection 2023.
9
Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment.人类单羧酸转运蛋白1(hMCT1)和4(hMCT4)在肿瘤细胞及肿瘤微环境中的作用
Cancer Manag Res. 2023 Sep 4;15:957-975. doi: 10.2147/CMAR.S421771. eCollection 2023.
10
Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell Line.乳酸/质子单羧酸转运蛋白4缺失通过AMPK/ACC途径诱导铁死亡并抑制人膀胱癌5637细胞系的自噬。
J Oncol. 2023 Jan 21;2023:2830306. doi: 10.1155/2023/2830306. eCollection 2023.